Identification of de novo EP300 and PLAU variants in a patient

Por um escritor misterioso
Last updated 12 abril 2025
Identification of de novo EP300 and PLAU variants in a patient
Identification of de novo EP300 and PLAU variants in a patient
Genes, Free Full-Text
Identification of de novo EP300 and PLAU variants in a patient
A novel de novo MTOR gain-of-function variant in a patient with Smith-Kingsmore syndrome and Antiphospholipid syndrome
Identification of de novo EP300 and PLAU variants in a patient
iPSC-derived neurons of CREBBP- and EP300-mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability - ScienceDirect
Identification of de novo EP300 and PLAU variants in a patient
About - DECIPHER v11.23
Identification of de novo EP300 and PLAU variants in a patient
Cancers, Free Full-Text
Identification of de novo EP300 and PLAU variants in a patient
Exploration of Coding and Non-coding Variants in Cancer Using GenomePaint - ScienceDirect
Identification of de novo EP300 and PLAU variants in a patient
Variant recurrence in neurodevelopmental disorders: the use of publicly available genomic data identifies clinically relevant pathogenic missense variants - ScienceDirect
Identification of de novo EP300 and PLAU variants in a patient
Zebrafish ep300 knockdown models Rubinstein Taybi Syndrome-2. (a-d)
Identification of de novo EP300 and PLAU variants in a patient
Genes associated with SE and/or occupied by EP300 are downregulated by
Identification of de novo EP300 and PLAU variants in a patient
Overview of sequence variants in CDH patients. (A) Number of validated
Identification of de novo EP300 and PLAU variants in a patient
Schematic representation (not in scale) of the CBP (A) and p300 (B)
Identification of de novo EP300 and PLAU variants in a patient
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis

© 2014-2025 trend-media.tv. All rights reserved.